Source: Pituitary. Unidade: FM
Subjects: POLIMORFISMO, RECEPTORES DA SOMATOTROFINA, GENÓTIPOS, RESULTADO DE TRATAMENTO, AVALIAÇÃO DE PROCESSOS E RESULTADOS, ACROMEGALIA, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JALLAD, Raquel S. et al. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly. Pituitary, v. 18, n. 5, p. 666-673, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007%2Fs11102-014-0629-y. Acesso em: 02 maio 2024.APA
Jallad, R. S., Trarbach, E. B., Duarte, F. H., Jorge, A. A. L., & Bronstein, M. D. (2015). Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly. Pituitary, 18( 5), 666-673. doi:10.1007/s11102-014-0629-yNLM
Jallad RS, Trarbach EB, Duarte FH, Jorge AAL, Bronstein MD. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly [Internet]. Pituitary. 2015 ; 18( 5): 666-673.[citado 2024 maio 02 ] Available from: http://link.springer.com/article/10.1007%2Fs11102-014-0629-yVancouver
Jallad RS, Trarbach EB, Duarte FH, Jorge AAL, Bronstein MD. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly [Internet]. Pituitary. 2015 ; 18( 5): 666-673.[citado 2024 maio 02 ] Available from: http://link.springer.com/article/10.1007%2Fs11102-014-0629-y